2′-C-Methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus
- 1 March 2007
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 73 (3) , 161-168
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak responseVaccine, 2005
- Design, Synthesis, and Antiviral Activity of 2‘-Deoxy-2‘-fluoro-2‘-C-methylcytidine, a Potent Inhibitor of Hepatitis C Virus ReplicationJournal of Medicinal Chemistry, 2005
- Structure of Foot-and-Mouth Disease Virus RNA-dependent RNA Polymerase and Its Complex with a Template-Primer RNAJournal of Biological Chemistry, 2004
- Structure−Activity Relationship of Purine Ribonucleosides for Inhibition of Hepatitis C Virus RNA-Dependent RNA PolymeraseJournal of Medicinal Chemistry, 2004
- Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside AnalogsJournal of Biological Chemistry, 2003
- Novel Viral Disease Control Strategy: Adenovirus Expressing Alpha Interferon Rapidly Protects Swine from Foot-and-Mouth DiseaseJournal of Virology, 2003
- Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structureProgress in Biophysics and Molecular Biology, 1993
- Foot-and-Mouth Disease and Its Antigens1985
- Portraits of Viruses: Foot-and-Mouth Disease VirusIntervirology, 1982
- Inhibitors of foot-and-mouth disease virusArchives of Virology, 1974